To provide proof-of-concept data on the efficacy/safety of transplanting HCV positive donor grafts in HCV sero-negative liver recipients who are currently listed.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
89
A HCV negative or previously successfully treated recipient with a HCV positive liver graft
Loma Linda University Transplant Institute
Loma Linda, California, United States
Patient survival rate
Will track all subjects post transplant for 15 months
Time frame: From the date of transplant through the last day of 15 month post transplant
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.